Treatment for Anxiety in Children

Status Completed

Clinical Trial Summary

The purpose of this study is to see if it is effective to treat children with anxiety disorders with fluvoxamine.

Fluvoxamine has been successfully used to treat obsessive-compulsive disorder (OCD) in adults and children. Anxiety disorders other than OCD, such as generalized anxiety disorder, social phobia, or separation anxiety, are very common in youth and are not always responsive to behavioral therapies alone. These disorders may respond to fluvoxamine.

A child will be evaluated for 3 weeks before he/she is assigned randomly (like tossing a coin) to receive either fluvoxamine or an inactive placebo for 8 weeks. After this double-blind phase (neither the child/parents nor the doctor know which treatment is being given), the child will have the option of continuing treatment during a 4-month open-label extension period (both the child/parents and the doctor know which the child is receiving).

A child may be eligible for this study if he/she:

Is 6 to 17 years old and has been diagnosed with an anxiety disorder (i.e., generalized anxiety disorder, social phobia, or separation anxiety).

Clinical Trial Description

To evaluate fluvoxamine in the treatment of children and adolescents with anxiety disorders.

Fluvoxamine is a serotonin reuptake inhibitor that is FDA-approved for the treatment of obsessive-compulsive disorder (OCD) in adults and children. Anxiety disorders other than OCD are very common in youth and are not always responsive to psychosocial therapies. Fluvoxamine is an alternative treatment.

After a 3-week period of evaluation, patients meeting study entry criteria are randomized to receive either fluvoxamine or placebo for 8 weeks. After this double-blind phase, patients can enter a 4-month open-label extension. ;

Study Design

Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00000389
Study type	Interventional
Source	National Institute of Mental Health (NIMH)
Contact
Status	Completed
Phase	Phase 3
Start date	October 1996
Completion date	November 1999

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03535805` - Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances	N/A
Active, not recruiting	`NCT05006976` - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study	N/A
Recruiting	`NCT05419934` - EMDR Therapy in Young Children, a Double-blinded Randomized Controlled Trial	N/A
Active, not recruiting	`NCT04136054` - Better Sleep in Psychiatric Care - Anxiety and Affective Disorders	N/A
Completed	`NCT04091139` - Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong	Phase 2/Phase 3
Completed	`NCT04647318` - Physiological Response to Self-compassion Versus Relaxation	N/A
Active, not recruiting	`NCT05114824` - Acceptability and Feasibility of an 8-week Online Mindfulness-Based Cognitive Therapy Program Among Undergraduate Students	N/A
Recruiting	`NCT05843695` - Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety	N/A
Completed	`NCT05078450` - Mood Lifters Online for Graduate Students and Young Professionals	N/A
Not yet recruiting	`NCT06162624` - Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons	N/A
Not yet recruiting	`NCT05863637` - Intensive Short-Term Dynamic Psychotherapy (ISTDP) for Anxiety Diagnoses in a Primary Care Setting	N/A
Not yet recruiting	`NCT05747131` - Emotion Detectives In-Out: Feasibility and Efficacy of a Blended Version of the Unified Protocol for Children	N/A
Not yet recruiting	`NCT05225701` - Efficacy of a Transdiagnostic Guided Internet-Delivered Intervention for Emotional, Trauma and Stress-Related Disorders.	N/A
Completed	`NCT02579915` - Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders (AIM-PC)	N/A
Recruiting	`NCT02186366` - Efficacy Study of Abdominal Massage Therapy to Treat Generalized Anxiety Disorder of Deficiency of Both Heart and Spleen Type	N/A
Recruiting	`NCT02376959` - Effect of Spiritist "Passe" Energy Therapy in Reducing Anxiety in Volunteers	N/A
Not yet recruiting	`NCT02126787` - Short-term, Intensive Psychodynamic Group Therapy Versus Cognitive-behavioral Group Therapy in the Day Treatment	N/A
Completed	`NCT02134730` - School-based Universal Prevention for Anxiety and Depression in Sweden: A Cluster-randomized Trial	N/A
Withdrawn	`NCT01953042` - Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders	N/A
Completed	`NCT01333098` - Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders	Phase 1/Phase 2